Researchers from the Republic of Korea have found that the efficacy of tenofovir disoproxil fumarate monotherapy is comparable to that of TDF plus entecavir in chronic hepatitis B patients with genotypic resistance to entecavir.
from The Medical News http://ift.tt/1vHe7YC
from The Medical News http://ift.tt/1vHe7YC
No comments:
Post a Comment